Leslie E. Stolz

3.4k total citations · 1 hit paper
21 papers, 2.1k citations indexed

About

Leslie E. Stolz is a scholar working on Genetics, Molecular Biology and Rheumatology. According to data from OpenAlex, Leslie E. Stolz has authored 21 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Molecular Biology and 9 papers in Rheumatology. Recurrent topics in Leslie E. Stolz's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Urticaria and Related Conditions (9 papers) and Cellular transport and secretion (4 papers). Leslie E. Stolz is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers), Urticaria and Related Conditions (9 papers) and Cellular transport and secretion (4 papers). Leslie E. Stolz collaborates with scholars based in United States, Italy and Canada. Leslie E. Stolz's co-authors include John D. York, James F. Tobin, Thomas Braun, Kathryn R. Wagner, T Riebel, Markus Schuelke, Se‐Jin Lee, Christoph Hübner, Shuling Guo and Shannon M. Lemrow and has published in prestigious journals such as New England Journal of Medicine, Cell and Journal of Biological Chemistry.

In The Last Decade

Leslie E. Stolz

21 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child

2004 1.1k citations Markus Schuelke, Kathryn R. Wagner et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leslie E. Stolz United States	14	1.6k	758	439	352	320	21	2.1k
Satomi Mitsuhashi Japan	28	1.8k 1.2×	299 0.4×	249 0.6×	454 1.3×	299 0.9×	99	2.4k
Valérie Allamand France	30	2.4k 1.5×	589 0.8×	310 0.7×	347 1.0×	318 1.0×	69	2.9k
Natasha C. Chang Canada	15	1.5k 0.9×	313 0.4×	338 0.8×	133 0.4×	235 0.7×	23	1.9k
Dominique Daegelen France	25	1.5k 1.0×	228 0.3×	284 0.6×	363 1.0×	97 0.3×	51	1.9k
Aurora A. Burds United States	9	1.7k 1.1×	535 0.7×	176 0.4×	398 1.1×	90 0.3×	13	2.3k
Pengpeng Bi United States	21	1.6k 1.0×	265 0.3×	915 2.1×	174 0.5×	224 0.7×	27	2.3k
Behzad Moghadaszadeh United States	21	1.5k 0.9×	251 0.3×	155 0.4×	289 0.8×	274 0.9×	29	2.1k
Michiko Hayasaka Japan	14	1.6k 1.0×	184 0.2×	172 0.4×	421 1.2×	115 0.4×	22	2.0k
Gwenn M. Hansen United States	25	1.0k 0.7×	247 0.3×	165 0.4×	337 1.0×	59 0.2×	48	1.7k
Elizabeth Vafiadaki Greece	22	1.5k 1.0×	303 0.4×	351 0.8×	226 0.6×	118 0.4×	40	2.0k

Countries citing papers authored by Leslie E. Stolz

Since Specialization

Citations

This map shows the geographic impact of Leslie E. Stolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie E. Stolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie E. Stolz more than expected).

Fields of papers citing papers by Leslie E. Stolz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie E. Stolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie E. Stolz. The network helps show where Leslie E. Stolz may publish in the future.

Co-authorship network of co-authors of Leslie E. Stolz

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie E. Stolz. A scholar is included among the top collaborators of Leslie E. Stolz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie E. Stolz. Leslie E. Stolz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vafai, Scott B., Verena Karsten, Troy Lister, et al.. (2024). Abstract 4139206: Design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterol. Circulation. 150(Suppl_1). 7 indexed citations

Rubinstein, Eitan, Leslie E. Stolz, Albert L. Sheffer, Chris Stevens, & Athos Bousvaros. (2014). Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency. BMC Gastroenterology. 14(1). 71–71. 42 indexed citations

Craig, Timothy, Marc A. Riedl, Jonathan A. Bernstein, et al.. (2014). Characterization of Anaphylaxis After Ecallantide Treatment of Hereditary Angioedema Attacks. The Journal of Allergy and Clinical Immunology In Practice. 3(2). 206–212.e4. 30 indexed citations

Chyung, Yung, Bradley Vince, Ryan Iarrobino, et al.. (2014). A phase 1 study investigating DX-2930 in healthy subjects. Annals of Allergy Asthma & Immunology. 113(4). 460–466.e2. 44 indexed citations

MacGinnitie, Andrew J., Mark Davis‐Lorton, Leslie E. Stolz, & Raffi Tachdjian. (2013). Use of Ecallantide in Pediatric Hereditary Angioedema. PEDIATRICS. 132(2). e490–e497. 24 indexed citations

Lumry, William R., Jonathan A. Bernstein, Andrew J. MacGinnitie, et al.. (2013). Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: Open-label continuation study. Allergy and Asthma Proceedings. 34(2). 155–161. 23 indexed citations

Sheffer, Albert L., Andrew J. MacGinnitie, Marilyn Campion, Leslie E. Stolz, & William E. Pullman. (2013). Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks. Annals of Allergy Asthma & Immunology. 110(3). 184–188.e2. 20 indexed citations

MacGinnitie, Andrew J., Marilyn Campion, Leslie E. Stolz, & William E. Pullman. (2012). Ecallantide for treatment of acute hereditary angioedema attacks: Analysis of efficacy by patient characteristics. Allergy and Asthma Proceedings. 33(2). 178–185. 12 indexed citations

Stolz, Leslie E. & Albert L. Sheffer. (2011). Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema. Expert Review of Clinical Immunology. 8(1). 25–32. 10 indexed citations

10.

Stolz, Leslie E. & Patrick T. Horn. (2010). Ecallantide: A plasma kallikrein inhibitor for the treatment ofacute attacks of hereditary angioedema. Drugs of today. 46(8). 547–547. 12 indexed citations

11.

Stolz, Leslie E., et al.. (2006). Administration of myostatin does not alter fat mass in adult mice. Diabetes Obesity and Metabolism. 10(2). 135–142. 31 indexed citations

12.

Russell, Mary E., Mark I. Friedman, Stephen R. Mascioli, & Leslie E. Stolz. (2006). Off‐Label Use: An Industry Perspective on Expanding Use Beyond Approved Indications. Journal of Interventional Cardiology. 19(5). 432–438. 13 indexed citations

13.

Schuelke, Markus, Kathryn R. Wagner, Leslie E. Stolz, et al.. (2004). Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child. New England Journal of Medicine. 350(26). 2682–2688. 1075 indexed citations breakdown →

14.

Erbe, David V., Suyue Wang, Yanling Zhang, et al.. (2004). Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms. Molecular Pharmacology. 67(1). 69–77. 75 indexed citations

15.

York, John D., Shuling Guo, Audrey R. Odom John, Bryan D. Spiegelberg, & Leslie E. Stolz. (2001). An expanded view of inositol signaling. Advances in Enzyme Regulation. 41(1). 57–71. 76 indexed citations

16.

Tsujishita, Yosuke, et al.. (2001). Specificity Determinants in Phosphoinositide Dephosphorylation. Cell. 105(3). 379–389. 104 indexed citations

17.

Guo, Shuling, Leslie E. Stolz, Shannon M. Lemrow, & John D. York. (1999). SAC1-like Domains of Yeast SAC1,INP52, and INP53 and of Human Synaptojanin Encode Polyphosphoinositide Phosphatases. Journal of Biological Chemistry. 274(19). 12990–12995. 322 indexed citations

18.

Stolz, Leslie E., Chau Huynh, Jeremy Thorner, & John D. York. (1998). Identification and Characterization of an Essential Family of Inositol Polyphosphate 5-Phosphatases (INP51, INP52 and INP53 Gene Products) in the Yeast Saccharomyces cerevisiae. Genetics. 148(4). 1715–1729. 107 indexed citations

19.

Stolz, Leslie E., et al.. (1998). INP51, a Yeast Inositol Polyphosphate 5-Phosphatase Required for Phosphatidylinositol 4,5-Bisphosphate Homeostasis and Whose Absence Confers a Cold-resistant Phenotype. Journal of Biological Chemistry. 273(19). 11852–11861. 88 indexed citations

20.

Stolz, Leslie E. & Rocky S. Tuan. (1996). Hybridization of biotinylated oligo(dT) for Eukaryotic mRNA quantitation. Molecular Biotechnology. 6(3). 225–230. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact